End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.02 USD | -3.35% | -4.04% | -8.18% |
05-12 | Transcript : Can-Fite BioPharma Ltd. - Special Call | |
05-09 | Can-Fite BioPharma Ltd. Announces FDA Grants IND Clearance for Namodenoson to Treat MASH Patients in a Phase IIb Study | CI |
Chart: Technical Analysis
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- CANF Stock
- CANF Stock
- Charts Can-Fite BioPharma Ltd.